Compare CTOS & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CTOS | TWST |
|---|---|---|
| Founded | 1988 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.6B |
| IPO Year | N/A | 2018 |
| Metric | CTOS | TWST |
|---|---|---|
| Price | $6.52 | $45.72 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 9 |
| Target Price | $7.50 | ★ $50.22 |
| AVG Volume (30 Days) | 793.9K | ★ 1.4M |
| Earning Date | 03-03-2026 | 02-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,936,513,000.00 | $391,557,000.00 |
| Revenue This Year | $13.19 | $16.77 |
| Revenue Next Year | $5.15 | $15.06 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 7.39 | ★ 18.59 |
| 52 Week Low | $3.18 | $23.30 |
| 52 Week High | $6.80 | $54.74 |
| Indicator | CTOS | TWST |
|---|---|---|
| Relative Strength Index (RSI) | 58.15 | 68.16 |
| Support Level | $6.17 | $39.66 |
| Resistance Level | $6.80 | $48.21 |
| Average True Range (ATR) | 0.22 | 2.48 |
| MACD | 0.01 | 0.17 |
| Stochastic Oscillator | 59.91 | 73.79 |
Custom Truck One Source Inc is a one-stop-shop provider of specialty equipment in the electric utility transmission and distribution, forestry, telecom, waste management, rail, and infrastructure end-markets in North America. The company's segment includes Equipment Rental Solutions (ERS), Truck and Equipment Sales (TES), and Aftermarket Parts and Services (APS). It generates maximum revenue from the TES segment. Geographically, it derives a majority revenue from the United States.
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.